RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $11,745,000 | -0.4% | 543,990 | +1.5% | 0.12% | +3.5% |
| Q2 2019 | $11,796,000 | -20.2% | 536,173 | -0.6% | 0.11% | -18.7% |
| Q1 2019 | $14,785,000 | +6.8% | 539,391 | +4.8% | 0.14% | -4.1% |
| Q4 2018 | $13,840,000 | -3.0% | 514,873 | +5.3% | 0.14% | +21.8% |
| Q3 2018 | $14,262,000 | -8.7% | 488,943 | -2.1% | 0.12% | -16.8% |
| Q2 2018 | $15,615,000 | +62.5% | 499,512 | +3.5% | 0.14% | +49.0% |
| Q1 2018 | $9,607,000 | -28.8% | 482,764 | +4.0% | 0.10% | -29.9% |
| Q4 2017 | $13,487,000 | – | 464,109 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |